课题基金 / 基金详情

EVALUATION OF CHEMOPREVENTION AGENTS BY IN VITRO SCREENI

EVALUATION OF CHEMOPREVENTION AGENTS BY IN VITRO SCREENI
通过体外筛选评价化学预防药物
批准号:
6346793
负责人:
CATHY ABEITA
金额:
$27.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2002-01-31

项目摘要

项目成果

CATHY ABEITA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chemopreventive agents which inhibit or retard the cancer process in oral mucosa are urgently needed. In order to select potential chemical candidates for whole animal and human testing, in vitro screening is required. The culture of normal oral epithelial cells and immortalized oral epithelial cell lines (dysplastic oral epithelial cells are being used to screen potential chemopreventive agents. Initial growth inhibition or other cytotoxicity assays with the test chemopreventive agent present are being used to select appropriate concentration ranges for use in the subsequent transformation-inhibition assays. Five log dilutions from 1 mM or the highest soluble concentration in medium or in a solvent such as dimethylsulfoxide without solvent toxicity. Three endpoints are being used to measure response to exposure to potential chemopreventive agents. Three endpoints are Ki-67, RAR- , and apoptosis. Five nontoxic concentrations (at half-log dilutions) shall be measured for their ability to modulate each endpoint. Appropriate controls shall be simultaneously tested. The criteria for a positive and negative response shall be defined in the proposal. The ED50 (50% effective dose) shall be determined by a method determined by a standard protocol. The appropriate controls shall be used.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CYBER CODER FOR XML
SBIR, PHASE I TOPIC 179, ENCODING SURGICAL PATHOLOGY DAT
  • 批准号:
    6345586
  • 项目类别:
  • 资助金额:
    $9.92万
  • 财政年份:
    2000
  • 负责人:
    CATHY ABEITA
  • 依托单位:
SBIR PHASE I TOPIC 179, ENCODING SURGICAL PATHOLOGY DATA
  • 批准号:
    6333720
  • 项目类别:
  • 资助金额:
    $9.92万
  • 财政年份:
    2000
  • 负责人:
    CATHY ABEITA
  • 依托单位:
CYBER CODER FOR XML
海外基金